1. Home
  2. GAIA vs ONCY Comparison

GAIA vs ONCY Comparison

Compare GAIA & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gaia Inc.

GAIA

Gaia Inc.

HOLD

Current Price

$3.35

Market Cap

105.7M

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.98

Market Cap

106.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GAIA
ONCY
Founded
1988
1998
Country
United States
Canada
Employees
N/A
N/A
Industry
Movies/Entertainment
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
105.7M
106.1M
IPO Year
1999
1999

Fundamental Metrics

Financial Performance
Metric
GAIA
ONCY
Price
$3.35
$0.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$9.00
$6.00
AVG Volume (30 Days)
70.9K
660.5K
Earning Date
11-03-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$98,622,000.00
N/A
Revenue This Year
$11.55
N/A
Revenue Next Year
$11.08
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.80
N/A
52 Week Low
$2.93
$0.33
52 Week High
$6.39
$1.51

Technical Indicators

Market Signals
Indicator
GAIA
ONCY
Relative Strength Index (RSI) 23.16 44.01
Support Level $3.65 $0.88
Resistance Level $3.89 $1.00
Average True Range (ATR) 0.18 0.06
MACD -0.01 -0.00
Stochastic Oscillator 19.35 51.31

Price Performance

Historical Comparison
GAIA
ONCY

About GAIA Gaia Inc.

Gaia Inc is a video streaming service and community that provides curated conscious media in primary channels; Seeking Truth provides new and enlightening perspectives for today's changing world; Transformation provides a wealth of content in the niche areas of spiritual growth, personal development, and expanded consciousness; Alternative Healing channel features content focused on food and nutrition, holistic healing, alternative and integrative medicines, and longevity, and Yoga. Geographically, it derives a majority of its revenue from the United States and also has an International presence.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

Share on Social Networks: